Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients

Circulation

Volumn 94, Issue 4, 1996, Pages 698-703

  Benetos, Athanase ^a   Gautier, Sylvie ^a   Ricard, Sylvain ^b   Topouchian, Jirar ^a   Asmar, Roland ^a   Poirier, Odette ^b   Larosa, Emile ^d   Guize, Louis ^d   Safar, Michel ^a   Soubrier, Florent ^c   Cambien, François ^b  

^a HÔPITAL BROUSSAIS   (France)

^b INSERM   (France)

^c l'alimentation et l'Environnement   (France)

^d IPC   (France)

Author keywords

angiotensin; aorta; genetics; hypertension

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; AORTA; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY PULSE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEMORAL ARTERY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; RECEPTOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCIBILITY;

EID: 9544250399     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.4.698     Document Type: Article

References (33)

1. Safar ME. Therapeutic trials and large arteries in hypertension. Am Heart J. 1988;115:702-710.
2. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 3rd ed. London, UK: E Arnold; 1990:77-142, 216-269, 283-359, 398-437.
3. Dzau VJ, Safar ME. Large conduit arteries in hypertension: role of the renin-angiotensin system. Circulation. 1988;77:947-953.
4. Rogg H, Schmid A, de Gasparo M. Identification and characterisation of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun. 1990;173:416-422.
5. Dostal DE, Baker KM. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart: mediation by the AT1 receptor. Am J Hypertens. 1992;5:276-280.
6. Morishita R, Gibbons GH, Ellison KH, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest. 1994;94:978-984.
7. Bunkenburg B, van Amelsvoort T, Rogg H, Wood JM. Receptor-mediated effects of angiotensin II on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension. 1992;20:746-754.
8. Naftilan AJ, Pratt RE, Dzau VJ. Induction of c-fos, c-myc and PDGF A chain gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1419-1424.
9. Griffin SA, Brown WCB, Macpherson F, Macgrath JC, Wilson VG, Korsgaard N, Mulvany M, Lever AF. Angiotensin II causes vascular hypertrophy in part by a nonpressor mechanism. Hypertension. 1991; 17:626-635.
10. Bonithon-Kopp C, Ducimetiere P, Touboul PJ, Fève JM, Billaud E, Courbon C, Héraud V. Plasma angiotensin-converting enzyme activity and carotid wall thickening. Circulation. 1994;89:952-954.
11. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy B, Safar M, Benetos A. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994;23:74-82.
12. Shimamoto H, Shimamoto Y. Lisinopril improves aortic compliance and renal blood flow: comparison with nitrendipine. Hypertension. 1995;25:327-334.
13. Cambien F, Poirier O, Lecerf L, Evans A. Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
14. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II Type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24:63-69.
15. Benetos A, Topouchian J, Ricard S, Gautier S, Bonnardeaux A, Asmar R, Poirier O, Safar M, Soubrier F, Cambien F. Influence of angiotensin II Type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension. 1995; 26:44-47.
16. London GM, Marchais SJ, Safar MF, Genest AF, Guerin AP, Metivier F, Chedid K, London AM. Aortic and large artery compliance in end-stage renal failure. Kidney Int. 1990;37:137-142.
17. Avolio AP, Deng D, Fa-Quan D, Wei-Qiang L, Yao-Fei L, Zhen-Dong H, Lian-Fen X, O'Rourke MF. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Hypertension. 1985;71:202-210.
18. Asmar R, Benetos A, London G, Hugue C, Weiss Y, Topouchian J, Laloux B, Safar M. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Press. 1995;4:48-54.
19. Silas J, Barker A, Ramsay L. Clinical evaluation of Dinamap 845 automated blood pressure recorder. Br Heart J. 1980;43:202-204.
20. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992;20:1433.
21. Smulyan H, Csermely TJ, Mookherjee S, Warner RA. Effect of age on arterial distensibility in asymptomatic humans. Arteriosclerosis. 1983;3:199-205.
22. Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol. 1993;21:1497-1506.
23. Witteman JCM, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H, Hoffman A. J-shape relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343:504-507.
24. Tiret L, Bonnardeaux A, Poirier O, Ricard S, Marques-Vidal P, Evans A, Arveiler D, Luc G, Kee F, Ducimetiere P, Soubrier F, Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphism on the risk of myocardial infarction. Lancet. 1994;344:910-913.
25. Noda M, Katoh T, Takuwa N, Kumada M, Kurokawa K, Takuwa Y. Synergistic stimulation of parathyroid hormone-related peptide gene expression by mechanical stretch and angiotensin II in rat aortic smooth muscle cells. J Biol Chem. 1994;269:17911-17917.
26. Sudhir K, Wilson E, Chattergie K, Ives HE. Mechanical stress and collagen potentiate mitogenic activity of angiotensin II in rats vascular smooth muscle cells. J Clin Invest. 1993;92:3003-3007.
27. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJW, Watt CM. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension. 1993;21: 455-460.
28. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol F, Soubrier F. An insertion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
29. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human peripheral mononuclear cells: main expression in T lymphocytes under the influence of a genetic polymorphism. Biochem J. 1993;290:33-40.
30. Danser AHJ, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GAJ, Schunkert H. Angiotensin-converting enzyme in human heart. Circulation. 1995;92:1387-1388.
31. Castellano M, Mulesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, Salvetti M, Porteri E, Bettoni G, Kreutz R, Lindpaintner K, Agabiti Rosei E. Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in general population: the Vobarno study. Circulation. 1995;91:2721-2724.
32. Hayoz D, Rutschmann B, Perret F, Niederberger M, Tardy Y, Mooser V, Nussberger J, Waeber B, Brunner H. Conduit artery compliance and distensibility are not necessarily reduced in hypertension. Hypertension. 1992;20:1-6.
33. Laurent S, Girerd X, Mourad JM, Lacolley P, Beck L, Boutouyrie P, Mignot JP, Safar M. Elastic modulus of the radial artery wall material is not increased in patients with essential hypertension. Arterioscler Thromb Vasc Biol. 1994;14:1223-1231.